---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-031796"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2022-12-13T23:59:59+00:00"
generated_at: "2026-06-21T05:49:43.247297+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology reports record Q2 revenue of $14.3M, cuts FY growth outlook to 10-15%

## Summary
- Record quarterly revenue of $14.3M, up 21% YoY from $11.8M.
- Adjusted EBITDA of $686K, down from $743K in prior-year period.
- Operating income just $7K; gross margin fell to 48% from 52%.
- Full-year growth target revised to 10%-15% due to increased cancellations and economic slowdown.
- Cash on hand $10.8M, no debt; cash from operations $3.3M for the quarter.

## SEC filing metadata
- accession: 0001628280-22-031796
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2022-12-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828022031796/0001628280-22-031796-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828022031796/csbr-20221213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-031796
- JSON: https://secwatch.observer/filing/0001628280-22-031796.json
- Plain text: https://secwatch.observer/filing/0001628280-22-031796.txt

## Key facts
- Earnings Releases
  CHAMPIONS ONCOLOGY, INC. reported second quarter of fiscal 2023, ended October 31, 2022 results: revenue $14.3 million. Guidance lowered.
  - Period: second quarter of fiscal 2023, ended October 31, 2022
  - Revenue: $14.3 million
  - Guidance: lowered
  - Result: reported results
  source text: in such a filing. --- EX-99.1 (EX-99.1) --- NEWS One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Record Quarterly Revenue of $14.3 Million Hackensack, NJ – December 13 , 2022 – Champions Oncology, Inc. (Nasdaq: CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative
  evidence_url: https://www.sec.gov/Archives/edgar/data/771856/000162828022031796/0001628280-22-031796-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.